Monoclonal antibodies directed against streptococcus pneumoniae

C - Chemistry – Metallurgy – 12 – P

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12P 21/08 (2006.01) C12N 5/20 (2006.01) C12N 5/26 (2006.01)

Patent

CA 2074585

ABSTRACT OF THE DISCLOSURE Streptococcus pneumoniae is a major cause of systematic bacterial infections such as pneumonia, meningitis, otitis and bacteremia. Such infections can be rapidly diagnosed using a monoclonal antibody which is specific against the bacterium, and in particular against surface accessible proteins having molecular masses of 40-kDa and 67-kDa. 19

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Monoclonal antibodies directed against streptococcus pneumoniae does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Monoclonal antibodies directed against streptococcus pneumoniae, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies directed against streptococcus pneumoniae will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1434607

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.